OptimizeRx (OPRX) Operating Expenses (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Operating Expenses data on file, last reported at $19.4 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 19.07% year-over-year to $19.4 million; the trailing twelve-month figure through Mar 2026 stood at $65.9 million (down 17.51% YoY), and the FY2025 full-year result was $61.9 million, down 15.3% from the prior year.
• Operating Expenses rose to $19.4 million in Q1 2026, from $15.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $28.7 million in Q4 2023 to a low of $11.9 million in Q1 2022.
• A 5-year average of $16.7 million and a median of $15.5 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses soared 115.82% in 2023 and plunged 36.03% in 2024, its largest moves.
• Tracing OPRX's Operating Expenses over 5 years: stood at $13.3 million in 2022, then jumped by 115.82% to $28.7 million in 2023, then sank by 36.03% to $18.4 million in 2024, then decreased by 15.54% to $15.5 million in 2025, then grew by 25.22% to $19.4 million in 2026.
• Business Quant data shows OPRX's Operating Expenses at $19.4 million in Q1 2026, $15.5 million in Q4 2025, and $15.5 million in Q3 2025.